GibaldiM. Biopharmaceutics and clinical pharmacokinetics. 2nd ed. Philadelphia: Lea and Febiger, 1977: vii.
2.
BurtonMEBraterDCVaskoMR. Comparison of drug dosing methods. Clin Pharmacokinet1985; 10: 1–37.
3.
BarrWH. Principles of biopharmaceutics. Am J Pharmaceut Ed1968; 52: 958–81.
4.
RiegelmanSRowlandM. Effect of route of administration on drug disposition. J Pharmacokinet Biopharm1973; 1: 419–34.
5.
RowlandMTozerTN. Clinical pharmacokinetics: Concepts and applications. Philadelphia: Lea and Febiger, 1980: 16–33, 34–47.
6.
WellingPG. Effects of gastrointestinal disease on drug absorption. In: BenetLZ.MassoudNGambertoglioJG, eds. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984: 29–47.
7.
NiaziS. Textbook of biopharmaceutics and clinical pharmacokinetics. New York: Appleton-Century-Crofts, 1979: 41–73.
8.
GibaldiMPerrierD. Pharmacokinetics. New York: Marcel Dekker, 1982: 1–44, 145–98.
9.
MetzlerCM. Bioavailability—a problem in equivalence. Biometrics1974; 30: 309–17.
10.
BenetLZ. Effect of route of administration and distribution on drug action. J Pharmacokinet Biopharm1978; 6: 559–85.
11.
ThompsonPDMelmonKLRichardsonJA. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med1973; 78: 499–508.
12.
WilkinsonGRShandDG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther1975; 18: 377–90.
13.
BenetLZ. Pharmacokinetic parameters: Which are necessary to define a drug substance?Eur J Respir Dis1984; 65 (suppl 134): 45–61.
14.
MayerSEMelmonKLGilmanAG. Introduction: The dynamics of drug absorption, distribution, and elimination. In: GilmanAGGoodmanLSGilmanA, eds. The pharmacological basis of therapeutics. 6th ed. New York: Macmillan, 1980: 1–27.
